The Race for a Cure: Innovation and Investment in Parkinson's Drug Development
The strategic imperative within the Parkinson's Disease Therapeutics Market has fundamentally shifted from merely managing symptoms to actively pursuing disease-modifying and neuroprotective agents. This intense focus on innovation is the bedrock of the market's anticipated climb to USD 11.61 Billion by 2032. The current generation of treatments, while effective for motor symptoms, often leads...
0 Commentaires 0 Parts 190 Vue 0 Aperçu